Background-With aging and in cardiac disease, fibrosis caused by collagen deposition is increased, impairing contractility and providing a substrate for arrhythmia. In this study, we set out to identify genetic modifiers of collagen deposition in the heart by exploiting the genetic variability among F2 progeny of 129P2 and FVBN/J mice carrying the Scn5a tm1Care/+ mutation. Methods and Results-Relative amounts of collagen were determined in left ventricular myocardium of 65 F2-mice and combined with genome-wide genotypic and cardiac expression data to identify collagen quantitative trait loci (QTLs) and overlapping expression QTLs (eQTLs). A significant collagen QTL was identified on mouse Chr8; an additional collagen QTL was identified on mouse Chr2 after correction for a genetic covariate uncovered on Chr18 using multiple QTL mapping. Of the 24 eQTLs colocalizing with the Chr8-collagen QTL, 6 transcripts were correlated with relative collagen amount. Similarly, of the 7 eQTLs colocalizing with the Chr2-collagen QTL, 1 transcript, Gpr158, correlated with relative collagen. Of the 12 transcripts with an eQTLs in the Chr18-covariate region, only Fgf1 correlated with relative collagen amount. Furthermore, 2 of the transcripts, Pdlim3 (Chr8) and Itga6 (Chr2), with eQTLs overlapping with collagen QTLs, had a genetic covariate on Chr18 that coincided with the Chr18 collagen covariate locus. Application of recombinant human FGF1 to isolated cardiac fibroblasts in culture affected the level of expression of Pdlim3, Itga6, and Gpr158. Conclusions-We here mapped a possible novel genetic network modulating collagen deposition in mouse left ventricular myocardium. (Circ Cardiovasc Genet. 2014;7:790-798.)
C ardiac fibrosis because of collagen deposition increases with age and in disease. It is a prominent feature of several cardiomyopathies, such as hypertensive cardiac hypertrophy, the inherited cardiomyopathies, and cardiomyopathy following myocardial infarction. Cardiac fibrosis has also been associated with primary cardiac electric disease, namely sodium channelopathy caused by mutation in the SCN5A gene (encoding the major sodium channel isoform in heart), both in patient case reports 1, 2 as well as in Scn5a mouse models. 3, 4 
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Cardiac fibrosis reduces cardiac contractility and function. It also disturbs cell-cell coupling of cardiomyocytes, which in turn provides a substrate for arrhythmia. The development of drug therapies to prevent the development of cardiac fibrosis relies on knowledge of the molecular pathways involved. Uncovering genetic factors that play a role in the development of fibrosis is likely to provide insight into such pathways. Integrative genomic approaches, such as those that integrate genome-wide genotypic data with phenotypic and gene transcript abundance data, facilitate the identification of such genetic factors. 5, 6 Genetically segregating populations of mice or rats, such as filial generation 2 (F2) progeny, recombinant inbred lines, and outbred populations, offer powerful opportunities for such approaches because these combine phenotypic diversity with a known genetic background. 7 We set out to identify genetic modifiers of collagen deposition in the mouse heart. We used a disease-sensitized mouse F2 progeny (129.FVB.F2-Scn5a tm1Care/+ ) harboring the Scn5a tm1Care/+ mutation (previously referred to as Scn5a 1798insD/+ ), generated from a 129P2-Scn5a tm1Care/+ × FVBN/J-Scn5a tm1Care/+ cross. 8 The 129P2-Scn5a tm1Care/+ and FVBN/J-Scn5a tm1Care/+ mouse lines display different severity of cardiac sodium channelopathy 9 and have been previously exploited to map quantitative trait loci (QTLs) for electrocardiographic traits and arrhythmia susceptibility. 8 Tnni3k was identified as the gene underlying one of these loci in a subsequent study. 5 We here used an integrative genomics approach harnessing the genetic and phenotypic variability in the 129.FVB.F2-Scn5a tm1Care/ population to map genetic factors underlying collagen deposition in the heart. Using QTL and multiple QTL mapping (MQM) mapping, 10 we identified QTLs for collagen deposition (collagen QTLs) on mouse chromosome 2 and 8. We also identified a genetic covariate for cardiac collagen deposition on mouse chromosome 18. As genetic variation underlying a QTL may affect the trait through effects on gene expression, we overlaid cardiac expression QTL (eQTL) data from the same 129.FVB. F2-Scn5a tm1Care/+ cross with the 3 loci, identifying overlapping eQTLs. Cognate genes for the eQTLs at the 3 loci, representing candidate causal genes, were then investigated in cultured neonatal cardiac fibroblasts in vitro.
Methods

Mouse Breeding and Husbandry
The transgenic 129P2-Scn5a tm1Care/+ and FVBN/J-Scn5a tm1Care/+ mice were generated as previously described. 11 129.FVB.F1-Scn5a tm1Care/+ mice were reared from these mice and subsequently intercrossed to produce 129.FVB.F2-Scn5a tm1Care/+ progeny. All mice were supplied with the same SDS diet (SDS CRM (E) PL; Special Diets Services, UK) and water ad libitum and maintained on a 12-hour light/dark cycle in a temperature-and humidity-controlled environment. All experiments were performed in accordance with governmental and institutional guidelines for animal use in research.
Genotyping
All 129.FVB.F2-Scn5a tm1Care/+ mice were genotyped for the Scn5a tm1Care mutation as previously described 8 ; only mice heterozygous for the mutation were used. For the genome-wide scan, the 129.FVB.F2-Scn5a tm1Care/+ and 3 mice from each parental strain were genotyped across the 19 autosomes and X chromosome by means of an Illumina Golden Gate mouse medium density (768 SNP) panel as described previously 8 ; 587 SNPs of this panel are informative in the studied F2 mice.
Harvest and Dissection of Heart Samples
Mice were euthanized at 12 to 14 weeks by CO 2 -O 2 asphyxiation followed by cervical dislocation. Hearts were excised, washed in 1× PBS, and dissected left ventricular (LV) free-wall flash-frozen in liquid N 2 .
Protein Isolation and Analysis
Protein was isolated from left ventricular tissue using standard procedures. In short, cells/tissue were homogenized in ice-cold radioimmunoprecipitation assay (RIPA) buffer (50 mmol/L Tris HCl pH 7.6, 150 mmol/L NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with protease inhibitors (Complete Mini; Roche) and sodium orthovanadate (final concentration 0.5 mmol/L). The unsoluable parts were spun down (30 sec at 4°C, 13 000 rpm); the supernatant was transferred to a fresh tube. Protein concentrations were determined using a BCA protein assay kit (Thermo Fisher Scientific). Total levels of soluble collagen were determined using the Sircol Assay (Biocolor) according to the manufacturer's protocol and normalized to the total protein input. All experiments were performed in duplicate.
(Multiple) QTL Mapping
Genome-wide (Multiple) QTL mapping for the amount of collagen was performed using the R/qtl package in the statistical programming language R. 12, 13 Briefly, for all 587 informative markers in the 129. FVB.F2-Scn5a tm1Care/+ mice, association with the amount of collagen was tested, correcting for sex and assuming either an additive or dominant genetic model in 2 separate analyses. To detect possible interacting loci (MQM), this model (Y≈X+sex+sex:X+ε) was further expanded by including all markers on the chromosomes with suggestive association (logarithm of the odds>2.2, ie, Chr1, Chr2, Chr8, and Chr18) as model covariates, 1 chromosome at a time, followed by backwards elimination of markers that did not add significantly to the model. Markers were retained as covariates in the model at a nominal significance level of FDR <0.05 for the difference between the basic model and including the genetic covariate (referred to as cofactor in the R/qtl documentation). This resulted in the identification of a genetic covariate at Chr18 rs6361186. Significance levels for the LOD scores were determined based on a permutation FDR <0.05, resulting in an LOD threshold of 2.9 for significant collagen QTLs.
Fully processed (variance-stabilization transformation, quantilenormalized, log-transformed) gene expression microarray data were used as previously published 5 and deposited in the gene expression omnibus database (GSE27236). 5 Genome-wide (Multiple) eQTL mapping was performed using the R/eqtl package in the statistical programming language R. Briefly, for all 587 informative markers in the 129.FVB.F2-Scn5a tm1Care/+ mice, association with each transcript level (n=26 529) was tested, correcting for sex and assuming an additive genetic model. The model was further expanded by including evenly spaced, randomly placed genomic positions as model covariates to detect possible interacting loci. A multiple-transcript genome-wide significance threshold (P<1.88×10 −6 ; Bonferroni correction for 26 529 transcript traits) was applied; the corresponding empirical LOD threshold of 6.6 was determined using 100 000 permutations. The expression levels of transcripts for which we identified eQTLs colocalizing with the collagen QTLs were tested for nominal correlation (P<0.05) with collagen levels (Spearman correlation coefficient, ρ).
Cardiac Fibroblast Isolation and Culture
Neonatal mouse cardiac fibroblasts were isolated, in 2 independent experiments, according to a modified protocol described previously for rats. 14 In short, hearts were excised aseptically and large vessels and both atria were removed. Ventricular tissue of all littermates (11 and 8 pups, respectively) was pooled and cut into 2 to 3 mm small pieces and remaining blood was washed out. Tissue fragments were washed in medium and incubated on at 4°C in HBSS (Sigma, H4641) containing 0.1% d-glucose (Merck) with antibiotics and 0.41 μ/mL Trypsin 1:300 (USB22715). Next, the tissue fragments were incubated at 37°C in prewarmed DMEM41965 (Gibco) supplemented with antibiotics and 140 μ/mL collagenase II (Worthington, 4176) for 45 minutes. Gentle trituration with a plastic 5 mL pipet was then used to dissociate the cells, which were filtered through a 70 μm filter to remove remaining debris. Cells were plated on 1% gelatin-coated 6 well plates in DMEM41965, 10% FBS, antibiotics for 1 hour, after which the supernatant containing the cardiomyocytes was removed, and the attached fibroblasts were cultured for 48 hours in DMEM41965, 2% BSA, supplemented with antibiotics, insulin (SigmaI6634), l-carnitin (SigmaC0283), and l-glutamin (Gibco25030) in the presence or absence of 20 ng/mL recombinant human FGF1 (peprotech 100-17A). Cells were washed with PBS and scraped in 200 μl Trizol (Life technologies) per well. mRNA was isolated from these cell lysates according to the manufacturers' protocol.
qRT-PCR
mRNA expression levels of the candidate genes was determined in by quantification using the LightCycler system for real-time RT-PCR (Roche Applied Science). Quantitative PCR data were analyzed with the LinRegPCR program. 15, 16 All samples were processed in triplicate and expression levels were normalized to HPRT. A pairwise nonparametric Kruskal-Wallis test was used to assess differences between control and human recombinant FGF1 groups, significance was called at P<0.05.
Data Access
Expression data were deposited previously in the public gene expression omnibus database of NCBI GEO database: GSE27236. Genotype and collagen phenotypic data have been submitted to the mouse phenome database: http://qtlarchive.org/.
Results
Collagen QTL Mapping
The F2-cross used in this study to identify genetic modifiers of collagen deposition in heart has been described earlier. 5, 8 In brief, F2 progeny were generated from 129P2 and FVBN/J mice both carrying heterozygously the p.1795insD mutation in the cardiac sodium channel Scn5a (Scn5a tm1Care/+ ). Amounts of collagen (relative to total protein content) were determined in LV tissue of 65 129.FVB.F2-Scn5a tm1Care/+ mice and in mice from both parental strains with and without the mutation. No differences in the levels of collagen were observed between the 2 founder strains ( Figure 1 ). However, the 129.FVB. F2-Scn5a tm1Care/+ mice showed a large spread in relative collagen, suggesting the existence of segregating alleles affecting the trait in the founder strains. The relative amount of collagen was then used together with previously generated genotypic data from the same 129.FVB.F2-Scn5a tm1Care/+ animals 8 as input for QTL mapping. We thus detected a significant dominant QTL for cardiac collagen deposition on mouse chromosome 8 between rs3725286 and rs13479811 ( Figure 2A and 2B and Table 1 ). The FVBN/J allele at this locus was associated with a lower level of cardiac collagen ( Figure 3A ).
Multiple QTL Mapping
As we expected the involvement of multiple loci in the deposition of collagen, we investigated the possible existence of additional QTLs and possible genetic covariates using MQM. MQM provides a statistical approach for identifying genetic covariates in a data set based on a systematic screen of possible covariates as additional parameters in the multiple regression model of the trait. The approach protects against overfitting as the residual variance of the model is fixed. 10 All chromosomal regions with an LOD score >2.2 were systematically analyzed for the presence of possible covariate loci by MQM using an additive model. We thus identified a significant covariate (FDR<0.05) for collagen deposition at chromosome 18 (rs6361186; Figure 3A and Table 1 ). Furthermore, adding the Chr18 locus as a covariate in QTL mapping uncovered that an additional collagen QTL on Chr2 (rs3713397-c2.loc20; Figures 2A, 2C, and 3A and Table 1 ) was found. Table 1 provides an overview of the 3 identified loci, their respective borders, and LOD scores.
Overlay of the Identified QTLs With eQTL Data
As genetic variation underlying a QTL may act through effects on gene expression, we assessed the 1.5 LOD drop region around the identified collagen QTLs and the Chr18 covariate locus for overlapping eQTLs. These eQTLs were identified based on determination of gene transcript abundance in LV tissue from 109 129.FVB.F2-Scn5a tm1Care/+ mice and genotypic information in the same population. 5 We thus identified 24 significant eQTLs mapping within the 1.5 LOD-interval of the Chr8 collagen QTL (Table 2) , 7 significant eQTLs mapping within the Chr2 collagen QTL (Table 3) , and 12 mapping within the 1.5 LOD-interval of the Chr18 collagen covariate locus ( Table 4 ). The transcripts with a suggestive eQTL mapping to the Chr2, Chr8, and Chr18 loci are listed in Table I in  the Data Supplement. As causative transcripts are expected to correlate with the amount of collagen, we performed a Spearman correlation test on the identified transcripts. Of the 31 transcripts with significant eQTLs mapping to the Chr8 and Chr2 loci, 5 (Pdlim3, Tmem66, Rad23A, Lsm6m, and Tnks) and 1 (Gpr158) transcripts, respectively, correlated with the relative amount of collagen (nominal significance, P<0.05; Tables 2 and 3 and Figure 3B and 3C). Of the 12 transcripts with eQTLs underlying the Chr18 collagen covariate locus, the levels of Fgf1, assessed by 2 probes, showed a suggestive correlation with collagen (P=0.05 and P=0.09; Table 4 and Figure 3D ).
To identify possible covariates for the identified eQTLs, we performed MQM on all expressed transcripts, similar to the procedure followed for the mapping of collagen loci. This analysis revealed that the final model for the transcript of one of the Chr8 eQTLs, namely Pdlim3¸ had a significant (FDR<0.05) covariate at the exact same position (rs6361186) as the Chr18 covariate identified for collagen deposition (see Figure 3D for genotype effects of rs6361186 on the expression level of Pdlim3). Furthermore, a suggestive eQTL (see Table I in the Data Supplement) at the Chr2 locus, for the Itga6 transcript, and the Fgf1 eQTL also had a significant (FDR<0.05) covariate at rs6361186 ( Figure 3D ). In summary, we identified a genetic covariate at rs6361186 on Chr18 using an additive genetic model of cardiac collagen deposition, which was shared by the models for Pdlim3, Itga6, and Fgf1.
In total 12 012 covariates for eQTL models were identified for all transcripts tested. Of these models, 248 (out of the 26 838 transcripts tested, 0.92%) had a genetic covariate at rs6361186 on Chr18. The presence of this Chr18 covariate in 13% of the QTL models (4 out of 32; 1 collagen QTL and 31 eQTLs mapping at the collagen QTLs) identified in relation with LV collagen, thus, represents a 13-fold overrepresentation compared with random expectation (P<10 −9 ). An overview of the loci involved, the correlating transcripts with underlying eQTLs, and the covariates identified is given in Figure 4 for clarity. 
Effect of FGF1 on the Chr2 and Chr8 Candidates in Neonatal Cardiac Fibroblasts
As the collagen QTL model improved by including the covariate on Chr18, we next explored this association in vitro. Fibroblast growth factor 1, Fgf1 (also known as acidic fibroblast growth factor or aFgf) was the only Chr18 covariate locus gene for which the transcript both had a cis-eQTL at this locus and showed a (suggestive) correlation to cardiac collagen deposition. Fgf1 is known to be involved in an anti-fibrotic effect in the lungs, 17, 18 and increased expression of FGF1 has been reported in patients with idiopathic cardiomyopathy. 19 We therefore investigated the possible effect of Fgf1 on the expression levels of the genes with eQTLs overlapping the Chr2 and Chr8 collagen QTLs, in cultured neonatal cardiac fibroblasts from wild-type FVBN/J mice. Isolated cardiac fibroblasts were cultured for 48 hours with and without human recombinant FGF1 in the culture medium after which RNA was isolated and transcript levels of the eQTL cognate genes were determined by qRT-PCR ( Figure 5) .
Of the 6 genes with an eQTL at the Chr8 locus, and for which the transcript was correlated to collagen, only Pdlim3 was reduced (P=0.028) in the presence of FGF1. This is in accordance with the finding that Pdlim3 was the only transcript at Chr8 that had a significant covariate at the Chr18 Fgf1 locus. Of the genes with eQTLs at Chr2, the transcripts of Itga6 and Gpr158 were increased (P=0.0495 and P=0.025, respectively) in the presence of FGF1. No effects on the transcript levels of Fgf1, Col1a1, or Col3a1 were observed.
An overview of the genes involved and the direction of their involvement is given in Figure 6 . Note the opposite effects of human recombinant FGF1 on the final collagen levels through the different intermediate proteins. 
Discussion
We here applied an integrative genomics approach to identify novel genetic factors underlying deposition of collagen in heart. Using a genetically and phenotypically diverse mouse population (129.FVB.F2_Scn5a tgCare1/+ ), we identified 2 novel QTLs (Chr2 and Chr8) and 1 covariate region (Chr18) for cardiac collagen. Overlaying these results with eQTL data obtained in the same F2-cross and with data on correlation between cardiac transcript abundance and deposited collagen, we identified a possible novel network of genes with opposing effects on cardiac collagen levels.
Collagen is a normal component of the cardiac extracellular matrix. However, upon injury or stress (such as a myocardial infarction, hypertrophy, and age), the heart remodels and fibrotic scars are formed, a process in which collagen deposition is central. Fibrotic tissue hampers the normal function of the heart by reducing contractility and electric conductivity. 20 The identification of genes involved in collagen deposition will provide insight into the mechanisms determining the development of fibrosis in the setting of cardiac injury or stress.
MQM was developed as a technique to identify additional genetic loci after compensating for variation explained by other genetic loci (covariates). 12, 13 This allowed us to identify a genetic covariate locus on Chr18 for collagen deposition.
Similarly, MQM of cardiac gene expression data identified genetic covariates of eQTLs.
Integration of gene transcript MQM mapping and correlation data between transcript abundance and collagen deposition pointed to candidate genes at the collagen QTL loci. Although extensive validation is required, using this integrative genomics approach, we could uncover a potential regulatory network, where Fgf1 appears to both suppress and induce collagen deposition through Pdlim3 (Chr8) and Gpr158 (Chr2), respectively. This results in a net positive correlation between Fgf1 and cardiac collagen in the F2-cross, but in a balanced effect on collagen deposition in both parental strains and in the cultured neonatal cardiac fibroblasts. Thus, FVBN/J mice that have relatively higher levels of Fgf1 in the presence of concurrent higher levels of Gpr158 and lower levels of Pdlim3 have the same net amount of LV collagen as 129P2 mice that have lower levels of Fgf1 with concurrent lower levels of Gpr158 and higher levels of Pdlim3. In the F2 population, however, as the different alleles are now segregating, a much larger spread in the levels of collagen can be observed (Figure 1) , allowing the genetic dissection of these loci. These results provide an example of the power of such integrative genomic strategies to identify opposing effects using a genetically segregating population, rather than only typing the founding inbred mouse lines. Although the Scn5a mutation carried by the mutant mice we studied leads to enhanced fibrosis at old age, 9 collagen deposition at the age of killing (12-14 weeks) did not differ between mutant and wild-type mice of both strains (Figure 1) . The variability in the levels of collagen in the LV tissue that were detected by the Sircol assay in the F2 mice, therefore, likely reflect normal variation in collagen deposition. More experimental work will be required to test whether the putative gene network identified in this study also plays a role in modulation of collagen deposition in the setting of cardiac stress. Furthermore, it is interesting in future studies to conduct similar studies on collagen deposition with aging or in the setting of cardiac disease because these may uncover additional loci.
The human fibroblast growth factor family consists of 22 members. Fibroblast growth factors are multifunctional proteins with a wide variety of effects, including cell division, embryological patterning, and remodeling. 21 Although Fgf2 (basic fibroblast growth factor) is a known factor in the development of cardiac fibrosis, 22 the role of FGF1 (acidic fibroblast growth factor) in the heart has remained obscure. FGF1 was shown, however, to be overexpressed in cardiac tissue from patients with diverse idiopathic cardiomyopathies. 19 Pdlim3 is a PDZ and LIM domain-containing protein that is associated with the Z-disc of cardiac myocytes. Recently, a potentially pathogenic mutation (M60Tfs1X) in PDLIM3 was reported in a patient with dilated cardiac myopathy. 23 Mice deficient in Pdlim3 (Alp) develop right ventricular cardiomyopathy during development. 24 Pdlim3 enhances the capacity of α-actinin to cross-link actin filaments, suggesting that destabilization of actin-anchorage sites in cardiac muscle lies at the basis of the observed phenotype. 25 The data in our F2-cross show a positive correlation between Pdlim3 transcript levels and collagen deposition in the heart, indicating that tight regulation of this protein is essential for a proper balance between maintenance of the extracellular matrix and the formation of fibrotic scars. Gpr158, a relatively unstudied orphan member of class C of the large G-protein coupled receptor family, was recently implicated in the formation of tight junctions in ocular trabecular meshwork cells. 26 To our knowledge, no connection between Gpr158 and either fibrosis or cardiac function has been described to date. 
Strength and Limitations
Both the sample size and the genetic variability of the 129. FVB.F2-Scn5a tm1Care/+ cross are limited; undoubtedly, additional loci and genes underlying cardiac collagen deposition remain to be unravelled. Additional genetic differences between 129P2 and FVBN/J affecting cardiac collagen deposition may be present at the loci identified in this study. Further dissection of these loci in additional crosses or selected recombinant inbred lines with the founding haplotypes of these 2 strains could help to identify these additional genetic factors by reducing the haplotype size through additional recombinations.
The potential network described in this study will need to be validated in detail in model systems in vivo, with targeted deletion or overexpression of the different partners in the proposed network. It will be interesting to see how these targeted interferences will affect the phenotypic readout (ie, collagen deposition and possibly cardiac stress response) in different genetic backgrounds (eg, different combinations of alleles at the Chr2 and Chr8 loci).
Integrative genomics approaches, such as the study described here, are potentially powerful to identify genetic loci and genes underlying cardiovascular (disease) phenotypes. The challenge for such studies lies in the step from locus to gene and in the functional follow-up studies to validate the findings. Apart from studying expression level differences in the tissue and population under investigation (ie, eQTLs; see Ref. 27 for a recent review on harvesting the power of this approach), whole genome resequencing in many different inbred mouse (and rat) strains is now underway, potentially allowing the fast identification of causal genetic variants, including protein function changing variants. Furthermore, deep phenotyping of (novel) genetic reference panels, such as the collaborative cross, the diversity outbred, and longer existing panels, such as the BXD and the BXH/HXB in rat, will allow the generation of phenotypic networks and identification of the genetic controls of these. 28 
Conclusions
In conclusion, using MQM, we here mapped a putative novel genetic network that modulates collagen deposition in mouse LV myocardium. These results demonstrate the potential of integrative genomics on whole-genome genetic and transcriptional data in combination with careful phenotyping in a genetically diverse murine population, to unravel not only the genes underlying QTL, but their possible associations in biological networks as well. 
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None. Figure 6 . Scheme of direction of the effects of identified genes on each other. Directions of the effects of Pdlim3, Itga6, and Gpr158 are based on the direction of the correlation coefficient between the expression levels and collagen in the LV samples; directions of the effects of Fgf1 on Pdlim3, Itga6 and Gpr158 are based on the F2 data in combination with the in vitro validation.
